Fisher & Paykel downgrade drags NZX 50 lower as Pacific Edge jumps – Market close
Cancer tester Pacific Edge soared more than 54% on a key US Medicare draft ruling.
Original Source
Read the full article at Nzherald →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.